• National reports
• Tendances
• Drugs, key data
• Drugs, international challenges
• Monographs
• Methodology
• Papers
• Memo/posters/maps

Memo

Memo designed to respond to specific requests from authorities.

• March 2021: 1999-2019: changes in drug use and supply in France through the experience of the OFDT's TREND scheme - Summary
  (lire le rapport complet en français)

• January 2021: Main results of the Crack study in the Ile-de-France region - Overview
  (lire le rapport complet en français)

• December 2020: Impact of the Covid-19 lockdown on cannabis users in France. Results of the 2020 Cannabis Online survey
  (lire la version originale en français)

• December 2020: Drug use in prison : practices, consequences and responses - Summary
  (lire le rapport complet en français)

• November 2020: Changes in the cannabis market in France - Summary
  (lire le rapport complet en français)

• July 2020: National legislation and policies to reduce alcohol-related harm in the European Union
  (lire la version originale en français)

• June 2020: Drugs and addictions in overseas France - State of play and issues - Summary
  (lire le rapport complet en français)

• May 2020: Drug use, drug supply and professional practices in France at the time of COVID-19: qualitative cross-observations of the TREND scheme - bulletin TREND | COVID-19 n°2 / April-May 2020
  (lire la version originale en français)

• April 2020: Drug use, drug supply and professional practices in France at the time of COVID-19: qualitative cross-observations of the TREND scheme - bulletin TREND | COVID-19 n°1 / March-April 2020
  (lire la version originale en français)

• April 2020: Tobacco smoking and tobacco cessation in 2019
  (lire la version originale en français)

• October 2019: Levels of screen use at the end of adolescence in France in 2017
  (lire la version originale en français)

• June 2019: Cannabis legalisation in the United States - Towards a regulated market?
  (lire la version originale en français)

• April 2019: Tobacco smoking and tobacco cessation in 2018
  (lire la version originale en français)

• October 2018: Cannabis legalisation and regulations in Canada
  (lire la version originale en français)

• April 2018: Tobacco smoking and tobacco cessation in 2017
  (lire la version originale en français)

• June 2017: "25x-NBOMe" type molecules - Available information on the diffusion of a class of NPS in France
  (lire la version originale en français)

• May 2017: Tobacco smoking and tobacco cessation in 2016
  (lire la version originale en français)

• March 2017: Cannabis regulations in the United States
  (lire la version originale en français)

• March 2017: Analysis of drugs in sewage: an approach to assess substance use, applied to a prison setting
  (lire la version originale en français)

• December 2016: Legislations on narcotics in Europe in 2016: common points and differences
  (lire la version originale en français)

• March 2016: Legislation relating to cannabis use and possession: definitions and overview of the situation in Europe
  (lire la version originale en français)

• February 2016: Tobacco smoking and tobacco cessation in 2015
  (lire la version originale en français)

• September 2015: The social cost of drugs in France
  (lire la version originale en français)

• July 2014: Morphine sulphate consumption by French drug users: recent trends (2012-2013)
  (lire la version originale en français)

• June 2014: Use of ketamine in France: recent trends (2012-2013)
  (lire la version originale en français)

• February 2014: Results of the ETINCEL - OFDT electronic cigarette survey: Prevalence, purchase and use behaviours, reasons for using electronic cigarettes
  (lire la version originale en français)

Presentations, posters, maps

Presentations and posters made for conferences and other international events; maps.

• Poster made for the 6^th Global Alcohol Policy Conference (Dublin, 9–11 March 2020): Alcohol marketing strategies in environments valued by French youths: observations and perceptions (pdf)
  
  
• Presentation made for the 3^rd Lisbon Addictions 2019 conference (Lisbon, 23-25 October 2019) : 20 years of communication on drugs: what are the new challenges for a monitoring centre? (pdf)
  
  
• Presentation made for the 3^rd Lisbon Addictions 2019 conference (Lisbon, 23-25 October 2019) : Chemsex: experiences, harms and care. Key findings from the APACHES study (pdf)
  
  
• Presentation made for the 3^rd Lisbon Addictions 2019 conference (Lisbon, 23-25 October 2019) : Female-oriented medicosocial responses in French drug treatment facilities. Results from the Ad-femina survey (pdf)
  
  
• Presentation made for the 3^rd Lisbon Addictions 2019 conference (Lisbon, 23-25 October 2019) : Participation to the structured session organised by the Reitox network "Drug policy debates: how are routine monitoring data used?" with Case study from France on the use of data in the public debate on the legal approaches to the possession of drugs for personal use (pdf)
  
  
• Presentation made for the 3^rd Lisbon Addictions 2019 conference (Lisbon, 23-25 October 2019) : The first therapeutic community in French prisons: the rehabilitation unit for drug users in the Neuvic detention centre (URUD). A process evaluation one year after opening (pdf)
  
  
• Presentation made for the 13^th Annual Conference of the ISSDP (Paris, 22-24 May 2019) : A comparative perspective on the emerging cannabis regulatory frameworks - First outcomes and unintended consequences (Uruguay, USA/Colorado & Washington State, Canada) (pdf)
  
  
• Presentation made for the 13^th Annual Conference of the ISSDP (Paris, 22-24 May 2019) : Fentanyl and other opioids in France: Capturing online signals to prevent public health crisis (pdf)
  
  
• Presentation made for the 13^th Annual Conference of the ISSDP (Paris, 22-24 May 2019) : EnCLASS: an innovative study to contribute to drug policies analysis among school-students in France (pdf)
  
  
• Presentation made for the 13^th Annual Conference of the ISSDP (Paris, 22-24 May 2019) : Combining strategies: echoes from the APACHES chemsex study in France (pdf)
  
  
• Presentation made for the SALIS's 40^th Annual Conference / SALIS/AMHL's 3^rd Joint Conference (Berkeley, CA, 2-4 May 2018) : The history of the documentation on addiction in France - 30 years of a turbulent history - Maintaining access to information despite challenges (pdf)
  
  
• Presentation made for the 12^th Annual Conference of the ISSDP (Vancouver, 19-20 April 2018) : A comparative analysis of cannabis regulatory options in Colorado, Washington State and Uruguay - Findings from the CANNALEX study (2015-2017) & evidence for future drug policy (pdf)
  
  
• Presentation made for the 38th Salis/AMHL Conference (Denver, 4–7 May 2016): New cannabis regulations implemented in Americas: Perceptions and repercussions ine Europe (France, United Kingdom, Italy, Spain, Switzerland) (pps)
  
  
• Mapping of the legislation relating to the use and possession of cannabis within the EU-28 (March 2016) (jpg)
  
  
• Posters made for the Lisbon Addictions conference (23–25 September 2015): What is new on ecstasy in France? Shapes, rates and user perceptions - An exploratory research on benzodiazepines’ drug users - HBSC and ESPAD in France: a marriage of convenience, but not only! - Estimating the number of PDU with mortality data when drug-related deaths are under-reported (pdf)
  
  
• Mapping of the national cannabis laws on use or possession of small amounts for personal use in the European Union (1 August 2012) (pdf)
  
  Although cannabis is a classified narcotic drug placed under control by the United Nations and by all EU Member States, the measures adopted to control it at national level vary considerably.
  This summary map provides an overview of the legal approaches towards cannabis use or possession of small quantities of cannabis for personal use in the European Union (27) (on 1 August 2012).
  It maps the possible sanctions set out in the different countries of the EU for cannabis-related minor offences, such as use or possession of small quantities for personal use.
  It also shows which countries distinguish cannabis from other substances (giving cannabis-related offences a special legal treatment) and which countries gave legal status to the use of medicinal cannabis.
  
  
• Posters made for the EMCDDA 15 years conference organised in Lisbon, 6-8 May 2009 about opioid substitution treatments in France and the SINTES monitoring system (pdf)
  
  
• Poster made for the 38th World Congress of the International Institute of Sociology,. Budapest, 27-28 June 2008: Gender differences in drug use in France: a matter of social status? (pdf)